Bill

Bill > H743


MA H743

MA H743
Establishing a commission to study a state-wide drug repository program


summary

Introduced
03/29/2021
In Committee
05/27/2021
Crossed Over
Passed
Dead
12/31/2022

Introduced Session

192nd General Court

Bill Summary

Relative to establishing a special commission (including members of the General Court) to study and provide recommendations on the feasibility of implementing a drug repository program for high cost pharmaceuticals. Elder Affairs.

AI Summary

This bill establishes a special commission to study and provide recommendations on the feasibility of implementing a drug repository program for high-cost pharmaceuticals in Massachusetts, excluding Schedule I and II controlled substances. The commission will examine successful drug repository programs in other states, determine what parties should be permitted to donate and receive medication, focus on prescription drugs for chronic illness and cancer, and recommend guidelines and regulations to ensure public safety and potential consumer savings. The commission will consist of various state legislators and government officials, and will submit its report and findings by February 1, 2022.

Committee Categories

Health and Social Services

Sponsors (6)

Last Action

Accompanied a study order, see H5201 (on 10/13/2022)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...